- |||||||||| Trial completion, Enrollment change, Trial primary completion date, Metastases: Study of External Beam Radiotherapy to Thyroid Carcinoma (clinicaltrials.gov) - Oct 7, 2015
P2, N=62, Completed, Recruiting --> Completed Recruiting --> Completed | N=50 --> 62 | Trial primary completion date: Dec 2015 --> Aug 2015
- |||||||||| Trial primary completion date: The Observer Variation of Shear Wave Elastography (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=30, Recruiting, Trial primary completion date: May 2015 --> May 2016 Trial primary completion date: Dec 2014 --> Dec 2015
- |||||||||| Tepezza (teprotumumab-trbw) / Roche, Amgen
Enrollment closed, Trial primary completion date: Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease (clinicaltrials.gov) - Sep 22, 2015 P2, N=84, Active, not recruiting, N=80 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Sep 2017 --> Sep 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Mar 2016
- |||||||||| thyroxine / Generic mfg.
Trial withdrawal: Levothyroxine in Pregnant SLE Patients (clinicaltrials.gov) - Sep 10, 2015 P4, N=0, Withdrawn, Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Mar 2016 Terminated --> Withdrawn
- |||||||||| Enrollment change, Trial initiation date, Trial primary completion date: Thyroid Hormone Replacement for Subclinical Hypothyroidism (clinicaltrials.gov) - Jul 6, 2015
P4, N=540, Recruiting, Active, not recruiting --> Completed N=3000 --> 540 | Initiation date: Feb 2013 --> May 2014 | Trial primary completion date: Jun 2016 --> Nov 2016
- |||||||||| Caprelsa (vandetanib) / Sanofi
Trial completion, Enrollment change: CaprelsaReg: CAPRELSA (clinicaltrials.gov) - Jul 6, 2015 P=N/A, N=10, Completed, N=3000 --> 540 | Initiation date: Feb 2013 --> May 2014 | Trial primary completion date: Jun 2016 --> Nov 2016 Recruiting --> Completed | N=15 --> 10
- |||||||||| Mekinist (trametinib) / Novartis, BeiGene, pazopanib / Generic mfg.
Enrollment closed, Combination therapy, Metastases: Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma (clinicaltrials.gov) - Jun 20, 2015 P1, N=111, Active, not recruiting, Recruiting --> Suspended Recruiting --> Active, not recruiting
- |||||||||| Trial initiation date, Trial primary completion date, Surgery: Acupuncture for Reduction of Inflammation (clinicaltrials.gov) - Jun 12, 2015
P=N/A, N=20, Completed, Not yet recruiting --> Recruiting | Initiation date: Jun 2014 --> Nov 2014 Initiation date: Mar 2013 --> Jul 2013 | Trial primary completion date: Oct 2014 --> Jul 2014
- |||||||||| dexamethasone / Generic mfg.
Trial primary completion date, Surgery: Dexamethasone and Wound Healing After Thyroid Surgery (clinicaltrials.gov) - Jun 11, 2015 P=N/A, N=150, Recruiting, Initiation date: Mar 2013 --> Jul 2013 | Trial primary completion date: Oct 2014 --> Jul 2014 Trial primary completion date: Dec 2014 --> Jun 2015
- |||||||||| Mekinist (trametinib) / Novartis, BeiGene, pazopanib / Generic mfg.
Trial primary completion date, Combination therapy, Metastases: Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma (clinicaltrials.gov) - Jun 11, 2015 P1, N=111, Recruiting, Trial primary completion date: Dec 2013 --> Jun 2014 Trial primary completion date: May 2015 --> Dec 2015
- |||||||||| Trial completion, Enrollment change, IO biomarker: Autoimmune Thyroid Disease Genetic Study (clinicaltrials.gov) - May 28, 2015
P=N/A, N=199, Completed, Recruiting --> Completed Active, not recruiting --> Completed | N=4000 --> 199
- |||||||||| Enrollment closed, Enrollment change, Trial primary completion date, Metastases: A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin (clinicaltrials.gov) - May 27, 2015
P2, N=8, Active, not recruiting, Active, not recruiting --> Completed | N=4000 --> 199 Recruiting --> Active, not recruiting | N=25 --> 8 | Trial primary completion date: Dec 2018 --> Sep 2016
- |||||||||| Enrollment open, Trial primary completion date, Surgery: The Efficacy and Safety of Thunderbeat in Thyroid Surgery (clinicaltrials.gov) - May 22, 2015
P=N/A, N=1, Recruiting, Recruiting --> Active, not recruiting | N=25 --> 8 | Trial primary completion date: Dec 2018 --> Sep 2016 Not yet recruiting --> Recruiting | Trial primary completion date: Mar 2015 --> Jun 2015
- |||||||||| prednisone / Generic mfg.
Trial completion: Short-term Prednisone to Treat STA Study(SPTSS) (clinicaltrials.gov) - May 20, 2015 P4, N=40, Completed, Not yet recruiting --> Recruiting | Trial primary completion date: Mar 2015 --> Jun 2015 Recruiting --> Completed
- |||||||||| Trial completion, Enrollment change, Trial primary completion date, Surgery: Acupuncture for Reduction of Inflammation (clinicaltrials.gov) - Apr 16, 2015
P=N/A, N=20, Completed, Recruiting --> Active, not recruiting Recruiting --> Completed | N=30 --> 20 | Trial primary completion date: Apr 2015 --> Oct 2014
- |||||||||| Trial primary completion date: Thyroid Disease Serum Repository (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=1000, Recruiting, Recruiting --> Completed | N=30 --> 20 | Trial primary completion date: Apr 2015 --> Oct 2014 Trial primary completion date: May 2015 --> May 2016
|